Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.10.30.685693

Impact of dietary synbiotics on growth performance, gut morphology, and immune function, and welfare indicators of broiler chickens with or without early life antibiotic supplementation via drinking water

Abstract

The widespread use of antibiotics in broiler production has contributed to antimicrobial resistance, necessitating the development of sustainable alternatives. Synbiotics, combining probiotics and prebiotics in a synergistic formulation, have emerged as promising candidates to replace antibiotics. This study evaluated the efficacy of dietary synbiotics as alternatives to early-life antibiotic supplementation in broiler chickens, examining their effects on growth performance, gut morphology, and welfare. A total of 80 mixed-sex Cobb 500 broiler chickens were allocated to a 2 x 2 factorial design investigating synbiotic supplementation (Bacillus subtilis and dried fermented Saccharomyces cerevisiae extract) and enrofloxacin treatment (days 0-5) administered via drinking water. During the initial growth period (days 0-7), synbiotic supplementation reduced body weight gain compared to controls. However, synbiotic x antibiotic interactions were observed during days 7-14 and 14-21, where synbiotics without antibiotics produced the highest weight gain in the second week, while controls without either treatment achieved superior performance in the third week. Feed intake was increased by synbiotic supplementation during days 7-14, while antibiotic treatment consistently elevated feed consumption throughout multiple periods and overall trial duration. Feed conversion efficiency was initially impaired by synbiotics (days 0-7) but improved during days 14-21. Antibiotic supplementation resulted in a poorer overall feed conversion ratio. Gut morphological analysis revealed significant synbiotic x antibiotic interactions for duodenal length and empty weights of duodenum and caeca, with synbiotics enhancing these parameters only when combined with antibiotic treatment. Both synbiotic and antibiotic supplementation independently reduced ileal content weight, while antibiotic treatment specifically decreased ileal weight and caecal length. Immune function evaluation through heterophil-to-lymphocyte ratios demonstrated a tendency for interaction, where synbiotics reduced this ratio in the absence of antibiotics but showed no effect when combined with antibiotic treatment. Neither treatment affected spleen or bursa weights, indicating minimal impact on immune organ development. These findings suggest that while dietary synbiotics show promise as alternatives to antibiotics in broiler production, their efficacy varies depending on concurrent antibiotic exposure and growth phase. Synbiotics demonstrated beneficial effects on gut morphology and stress markers, particularly when administered without concurrent antibiotic treatment, supporting their potential as functional alternatives in antimicrobial-free poultry production.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Karunaratne, N. D., De Seram, E. L., Perera, K., Musny, M., Weththasinghe, P.. 2025-10-31. Impact of dietary synbiotics on growth performance, gut morphology, and immune function, and welfare indicators of broiler chickens with or without early life antibiotic supplementation via drinking water. https://doi.org/10.1101/2025.10.30.685693

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗